BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kurata Y, Kuzuya T, Miwa Y, Iwasaki K, Haneda M, Amioka K, Yamada K, Watarai Y, Katayama A, Uchida K, Kobayashi T. Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation. International Immunopharmacology 2014;22:384-91. [DOI: 10.1016/j.intimp.2014.07.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Iwasaki K, Kitahata N, Miwa Y, Uchida K, Matsuoka Y, Horimi K, Kobayashi T. Suppressive Effect of Everolimus on IL-2, IL-10, IL-21, and IFNγ Levels: Implications for the Successful Minimization of Calcineurin Inhibitor Use in Transplantation. Therapeutic Drug Monitoring 2019;41:371-5. [DOI: 10.1097/ftd.0000000000000630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
3 Wang X, Qin W, Chen W, Liu H, Zhang D, Zhang X, Li P. Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay. Exp Ther Med 2021;21:191. [PMID: 33488800 DOI: 10.3892/etm.2021.9623] [Reference Citation Analysis]
4 Dieplinger G, Everly MJ, Briley KP, Haisch CE, Bolin P, Maldonado AQ, Kendrick WT, Kendrick SA, Morgan C, Terasaki PI. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction. Transpl Infect Dis. 2015;17:848-858. [PMID: 26442607 DOI: 10.1111/tid.12467] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]